Cite This Page

Jump to navigation Jump to search

Bibliographic details for 18561331. METHODS OF TREATMENT OF CANCER PATIENTS HAVING ALTERED SETD2 BIOMARKER WITH A PD-1 ANTAGONIST simplified abstract (Merck Sharp & Dohme LLC)

Citation styles for 18561331. METHODS OF TREATMENT OF CANCER PATIENTS HAVING ALTERED SETD2 BIOMARKER WITH A PD-1 ANTAGONIST simplified abstract (Merck Sharp & Dohme LLC)

APA style

18561331. METHODS OF TREATMENT OF CANCER PATIENTS HAVING ALTERED SETD2 BIOMARKER WITH A PD-1 ANTAGONIST simplified abstract (Merck Sharp & Dohme LLC). (2024, July 26). WikiPatents, . Retrieved 05:53, October 20, 2024 from http://wikipatents.org/index.php?title=18561331._METHODS_OF_TREATMENT_OF_CANCER_PATIENTS_HAVING_ALTERED_SETD2_BIOMARKER_WITH_A_PD-1_ANTAGONIST_simplified_abstract_(Merck_Sharp_%26_Dohme_LLC)&oldid=206319.

MLA style

"18561331. METHODS OF TREATMENT OF CANCER PATIENTS HAVING ALTERED SETD2 BIOMARKER WITH A PD-1 ANTAGONIST simplified abstract (Merck Sharp & Dohme LLC)." WikiPatents, . 26 Jul 2024, 05:13 UTC. 20 Oct 2024, 05:53 <http://wikipatents.org/index.php?title=18561331._METHODS_OF_TREATMENT_OF_CANCER_PATIENTS_HAVING_ALTERED_SETD2_BIOMARKER_WITH_A_PD-1_ANTAGONIST_simplified_abstract_(Merck_Sharp_%26_Dohme_LLC)&oldid=206319>.

MHRA style

WikiPatents contributors, '18561331. METHODS OF TREATMENT OF CANCER PATIENTS HAVING ALTERED SETD2 BIOMARKER WITH A PD-1 ANTAGONIST simplified abstract (Merck Sharp & Dohme LLC)', WikiPatents, , 26 July 2024, 05:13 UTC, <http://wikipatents.org/index.php?title=18561331._METHODS_OF_TREATMENT_OF_CANCER_PATIENTS_HAVING_ALTERED_SETD2_BIOMARKER_WITH_A_PD-1_ANTAGONIST_simplified_abstract_(Merck_Sharp_%26_Dohme_LLC)&oldid=206319> [accessed 20 October 2024]

Chicago style

WikiPatents contributors, "18561331. METHODS OF TREATMENT OF CANCER PATIENTS HAVING ALTERED SETD2 BIOMARKER WITH A PD-1 ANTAGONIST simplified abstract (Merck Sharp & Dohme LLC)," WikiPatents, , http://wikipatents.org/index.php?title=18561331._METHODS_OF_TREATMENT_OF_CANCER_PATIENTS_HAVING_ALTERED_SETD2_BIOMARKER_WITH_A_PD-1_ANTAGONIST_simplified_abstract_(Merck_Sharp_%26_Dohme_LLC)&oldid=206319 (accessed October 20, 2024).

CBE/CSE style

WikiPatents contributors. 18561331. METHODS OF TREATMENT OF CANCER PATIENTS HAVING ALTERED SETD2 BIOMARKER WITH A PD-1 ANTAGONIST simplified abstract (Merck Sharp & Dohme LLC) [Internet]. WikiPatents, ; 2024 Jul 26, 05:13 UTC [cited 2024 Oct 20]. Available from: http://wikipatents.org/index.php?title=18561331._METHODS_OF_TREATMENT_OF_CANCER_PATIENTS_HAVING_ALTERED_SETD2_BIOMARKER_WITH_A_PD-1_ANTAGONIST_simplified_abstract_(Merck_Sharp_%26_Dohme_LLC)&oldid=206319.

Bluebook style

18561331. METHODS OF TREATMENT OF CANCER PATIENTS HAVING ALTERED SETD2 BIOMARKER WITH A PD-1 ANTAGONIST simplified abstract (Merck Sharp & Dohme LLC), http://wikipatents.org/index.php?title=18561331._METHODS_OF_TREATMENT_OF_CANCER_PATIENTS_HAVING_ALTERED_SETD2_BIOMARKER_WITH_A_PD-1_ANTAGONIST_simplified_abstract_(Merck_Sharp_%26_Dohme_LLC)&oldid=206319 (last visited October 20, 2024).

BibTeX entry

 @misc{ wiki:xxx,
   author = "WikiPatents",
   title = "18561331. METHODS OF TREATMENT OF CANCER PATIENTS HAVING ALTERED SETD2 BIOMARKER WITH A PD-1 ANTAGONIST simplified abstract (Merck Sharp & Dohme LLC) --- WikiPatents{,} ",
   year = "2024",
   url = "http://wikipatents.org/index.php?title=18561331._METHODS_OF_TREATMENT_OF_CANCER_PATIENTS_HAVING_ALTERED_SETD2_BIOMARKER_WITH_A_PD-1_ANTAGONIST_simplified_abstract_(Merck_Sharp_%26_Dohme_LLC)&oldid=206319",
   note = "[Online; accessed 20-October-2024]"
 }

When using the LaTeX package url (\usepackage{url} somewhere in the preamble) which tends to give much more nicely formatted web addresses, the following may be preferred: 

 @misc{ wiki:xxx,
   author = "WikiPatents",
   title = "18561331. METHODS OF TREATMENT OF CANCER PATIENTS HAVING ALTERED SETD2 BIOMARKER WITH A PD-1 ANTAGONIST simplified abstract (Merck Sharp & Dohme LLC) --- WikiPatents{,} ",
   year = "2024",
   url = "\url{http://wikipatents.org/index.php?title=18561331._METHODS_OF_TREATMENT_OF_CANCER_PATIENTS_HAVING_ALTERED_SETD2_BIOMARKER_WITH_A_PD-1_ANTAGONIST_simplified_abstract_(Merck_Sharp_%26_Dohme_LLC)&oldid=206319}",
   note = "[Online; accessed 20-October-2024]"
 }


Retrieved from "http://wikipatents.org/index.php?title=Special:CiteThisPage"